Document Detail


Fungal peritonitis in patients on peritoneal dialysis.
MedLine Citation:
PMID:  8080003     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fungal peritonitis (FP) is a serious complication of peritoneal dialysis, both in terms of morbidity and mortality. Available data on the effectiveness of fluconazole in eradicating FP without catheter removal are still controversial. We reviewed 20 FP cases that occurred among 325 patients who underwent peritoneal dialysis in our center between January 1984 and January 1992, in order to establish whether a profile of patients at risk of developing FP could be identified and to evaluate the effectiveness of fluconazole in treating FP (7 cases). Age, sex, a particular cause of end-stage renal disease, and the presence of diabetes did not correlate significantly with the development of FP. The risk of FP increased in patients on immunosuppressive treatment. Sixteen of our 20 patients had bacterial peritonitis during the month before they developed FP. Nineteen were treated with antibiotics. Neither the type of bacterial organism isolated during the bacterial peritonitis preceding FP nor modality and duration of antibiotic treatment correlated significantly with the development of FP. Patients who subsequently developed FP were more frequently treated with antibiotics while in hospital (p < 0.001). Candida species accounted for 15 of our 20 FP cases (75%), with Candida albicans being by far the most common isolate. Treatment strategies varied among the 20 patients. The combination of intravenous or intraperitoneal administration of 5-fluorocytosine and oral administration of fluconazole was used in 7 cases: only 1 patient was cured without catheter removal, 1 patient died within the first 4 days of treatment, removal of peritoneal catheter was necessary in the other 5 patients.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
C Michel; L Courdavault; R al Khayat; B Viron; P Roux; F Mignon
Related Documents :
2676403 - Penetration of third-generation cephalosporins into human peritoneal tissue.
1361863 - The place for automated peritoneal dialysis.
16533893 - Sydenham's chorea in western pennsylvania.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American journal of nephrology     Volume:  14     ISSN:  0250-8095     ISO Abbreviation:  Am. J. Nephrol.     Publication Date:  1994  
Date Detail:
Created Date:  1994-10-04     Completed Date:  1994-10-04     Revised Date:  2007-02-14    
Medline Journal Info:
Nlm Unique ID:  8109361     Medline TA:  Am J Nephrol     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  113-20     Citation Subset:  IM    
Affiliation:
Service de Néphrologie, Hôpital Tenon, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents / therapeutic use*
Antifungal Agents / therapeutic use*
Candidiasis*
Drug Administration Routes
Drug Therapy, Combination
Female
Fluconazole / therapeutic use
Flucytosine / therapeutic use
Humans
Ketoconazole / therapeutic use
Kidney Failure, Chronic / etiology,  immunology,  therapy
Length of Stay
Male
Middle Aged
Mycoses*
Peritoneal Dialysis
Peritonitis / drug therapy*,  immunology,  microbiology
Risk Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Antifungal Agents; 2022-85-7/Flucytosine; 65277-42-1/Ketoconazole; 86386-73-4/Fluconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Procollagen type 1 C-terminal extension peptide serum levels following parathyroidectomy in hyperpar...
Next Document:  Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases.